PDCD1 and thyroid gland carcinoma: In thyroid cancer, high expression of METTL3 in tumor cells inhibits the demethylation of CD70mRNA, maintains the degradation of transcripts mediated by YTHDF2, thereby releasing T cells from suppression and enhancing the efficacy of PD-1 blockade (86).